Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Low Birth Weight May Mean Higher Risk For Kidney Disease
Parents of newborns who tip the scales at less than 5 ÷½ pounds should put some heavy thought to a possible future consequence: kidney disease. Low birth weight babies have a 70% greater risk of developing chronic kidney disease (CKD) in later life, according to research published in the August issue of the American Journal of Kidney Diseases, the official journal of the National Kidney Foundation.
generic viagra online
Obama Open To Using MedPAC To Set Medicare Payment Rates
As the administration searches for ways to pay for health care reform and restrain medical costs, President Obama suggested Wednesday that he would consider transferring the power to set Medicare reimbursement rates from Congress to the independent advisory agency known as MedPAC, MedPage Today reports. The move reflects legislation introduced by Sen. Jay Rockefeller, D-W.Va., last month that would move MedPAC into the executive branch as "a regulatory board similar to the Federal Reserve ... The move would transfer the power to set reimbursement rates from Congress -- and perhaps the interest groups that lobby it -- to an agency that critics say is better equipped to make nuanced medical payment decisions" (Walker 3/09).
News of the day
Prospective Clinical Advantages Of Trabecular Metal(TM) Technology Highlighted In Comparative Study
Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH) announced that data from a comparative clinical study conducted by researchers at the Mayo Clinic and the Joint Replacement Surgeons of the Indiana Research Foundation describes the low stiffness and osteoconductive properties of Zimmer"s Trabecular Metal Technology. The study, published in The Journal of Arthroplasty, found significant reductions in acetabular bone loss adjacent to the Trabecular Metal device compared to the titanium component, and a significant relative increase in bone mineral density (BMD) after total hip arthroplasty (THA) using implants made with Zimmer"s proprietary Trabecular Metal Technology.
Diagnostics

High-Grade Prostate Cancer Outcomes Treated With Combination Of Brachytherapy, External Beam Radiotherapy And Hormonal Therapy

UroToday.com - In the online edition of the BJU International, Dr. Richard Stock and colleagues from Mt. Sinai School of Medicine in New York reported on their outcomes using combined radiotherapy approach to men with high-risk prostate cancer (CaP). The study cohort include 181 men with Gleason score 8-10 CaP treated with androgen deprivation therapy (ADT), brachytherapy, and external beam radiotherapy (ERBT) in combination between 1994 and 2006. The study is non-randomized, single institution and retrospective. The ADT was for 3 months followed by brachytherapy and then 2 months later concomitant ADT and ERBT were delivered. The total ADT duration was 9 months. 103Pd was the isotope for all brachytherapy and most men received a dose of 100Gy with 45Gy ERBT. Median follow-up was 65 months and the Phoenix definition of PSA recurrence was used. The overall 8-year actuarial freedom from biochemical failure was 73%. In 36 patients with a biochemical relapse, the median time to PSA failure was 33 months with 53% failing within 3 years. The median PSADT was 2.7 months. Metastatic CaP developed in 22 patients and the 8-year freedom from distant metastases rate was 80%. The cancer-specific survival and overall survival at 8 years were 87% and 79%, respectively. In men experiencing PSA relapse, the 8-year CSS and overall survival were 53% and 51%, respectively. In multivariable analysis, only Gleason score and initial PSA significantly affected the development of biochemical failure. Toxicity from this treatment approach was not reported. Stock RG, Cesaretti JA, Hall SJ, Stone NN BJU Int. 2009 Jun 2. Epub ahead of print. doi:10.1111/j.1464-410X.2009.08661.x Written by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com Copyright © 2009 - UroToday Copyright: Medical News Today Not to be reproduced without permission of Medical News Today


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009